PSNL — Personalis, Inc. | BiotechEdge | BiotechEdge

Catalysts Convergence Squeeze SignalsNEW Cash Runway Insiders M&A Research

Home›Companies›Personalis, Inc. (PSNL)

Personalis, Inc.

PSNL

Held by 0 specialist biotech funds

Short interest: 19.8% of float.

Score Holdings Short Interest Catalysts Insiders Research

Signal Score

0.0/10

No fund positions

BiotechEdge

Catalysts Conferences Companies Convergence Fund Insiders Signals Squeeze Cash Runway Research Weekly Briefs 13F Changes Glossary PricingSign In Start 14-Day Free Trial

Data sourced from SEC EDGAR and ClinicalTrials.gov. Not investment advice.

Feedback

●●

No recent insider activity●●

No upcoming catalysts●●

Not held by tracked funds●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

PSNL is not currently held by any of our tracked specialist biotech funds.

Fund positions update quarterly with new 13F filings. Explore fund convergence to see which tickers multiple funds hold.

Short Interest

Short Shares

13.10M

Change

+11.5%

Days to Cover

7.2

% of Float

19.8%

Settlement

Apr 30, 2026

Short interest over 2 periods

Catalysts

No catalysts tracked.

Be first to know when this name moves

Fund buys and exits, insider activity, and catalyst alerts across 800+ biotechs — free Monday brief.

Activist Filings

SC 13GDeep Track Capital5.5%May 12, 2026

Position Details

No position data available.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Insider Signals

No insider purchases or sales detected in the past 90 days.

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Short Interest, Days to Cover, and Why Short Sellers Are the Third Expert Signal in Biotech

7 min read

Biotech Short Squeeze Indicators: How to Find and Evaluate Squeeze Candidates

8 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts:

Terms

Privacy

Disclaimer